Literature DB >> 15920156

Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice.

H Clarke Anderson1, Dympna Harmey, Nancy P Camacho, Rama Garimella, Joseph B Sipe, Sarah Tague, Xiaohong Bi, Kristen Johnson, Robert Terkeltaub, José Luis Millán.   

Abstract

We have shown previously that the hypomineralization defects of the calvarium and vertebrae of tissue nonspecific alkaline phosphatase (TNAP)-deficient (Akp2-/-) hypophosphatasia mice are rescued by simultaneous deletion of the Enpp1 gene, which encodes nucleotide pyrophosphatase phosphodiesterase 1 (NPP1). Conversely, the hyperossification in the vertebral apophyses typical of Enpp1-/- mice is corrected in [Akp2-/-; Enpp1-/-] double-knockout mice. Here we have examined the appendicular skeletons of Akp2-/-, Enpp1-/-, and [Akp2-/-; Enpp1-/-] mice to ascertain the degree of rescue afforded at these skeletal sites. Alizarin red and Alcian blue whole mount analysis of the skeletons from wild-type, Akp2-/-, and [Akp2-/-; Enpp1-/-] mice revealed that although calvarium and vertebrae of double-knockout mice were normalized with respect to mineral deposition, the femur and tibia were not. Using several different methodologies, we found reduced mineralization not only in Akp2-/- but also in Enpp1-/- and [Akp2-/-; Enpp1-/-] femurs and tibias. Analysis of calvarial- and bone marrow-derived osteoblasts for mineralized nodule formation in vitro showed increased mineral deposition by Enpp1-/- calvarial osteoblasts but decreased mineral deposition by Enpp1-/- long bone marrow-derived osteoblasts in comparison to wild-type cells. Thus, the osteomalacia of Akp2-/- mice and the hypomineralized phenotype of the long bones of Enpp1-/- mice are not rescued by simultaneous deletion of TNAP and NPP1 functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920156      PMCID: PMC1602415          DOI: 10.1016/S0002-9440(10)62481-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

Review 1.  Therapeutic approaches to bone diseases.

Authors:  G A Rodan; T J Martin
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

2.  Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia.

Authors:  P Nürnberg; H Thiele; D Chandler; W Höhne; M L Cunningham; H Ritter; G Leschik; K Uhlmann; C Mischung; K Harrop; J Goldblatt; Z U Borochowitz; D Kotzot; F Westermann; S Mundlos; H S Braun; N Laing; S Tinschert
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

3.  PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification.

Authors:  F Rutsch; S Vaingankar; K Johnson; I Goldfine; B Maddux; P Schauerte; H Kalhoff; K Sano; W A Boisvert; A Superti-Furga; R Terkeltaub
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

4.  Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture.

Authors:  H Fleisch; F Straumann; R Schenk; S Bisaz; M Allgöwer
Journal:  Am J Physiol       Date:  1966-09

5.  Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia.

Authors:  S Narisawa; N Fröhlander; J L Millán
Journal:  Dev Dyn       Date:  1997-03       Impact factor: 3.780

6.  Role of the mouse ank gene in control of tissue calcification and arthritis.

Authors:  A M Ho; M D Johnson; D M Kingsley
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

7.  Ultrastructure of early calcification in cervical ossification of the posterior longitudinal ligament.

Authors:  T Kubota; K Sato; H Kawano; S Yamamoto; A Hirano; Y Hashizume
Journal:  J Neurosurg       Date:  1984-07       Impact factor: 5.115

8.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.

Authors:  Lovisa Hessle; Kristen A Johnson; H Clarke Anderson; Sonoko Narisawa; Adnan Sali; James W Goding; Robert Terkeltaub; José Luis Millan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

9.  Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine.

Authors:  A Okawa; I Nakamura; S Goto; H Moriya; Y Nakamura; S Ikegawa
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

10.  Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.

Authors:  Dympna Harmey; Lovisa Hessle; Sonoko Narisawa; Kristen A Johnson; Robert Terkeltaub; José Luis Millán
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

View more
  49 in total

1.  Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation.

Authors:  Hwa Kyung Nam; Jin Liu; Yan Li; Andrew Kragor; Nan E Hatch
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Human stanniocalcin-1 or -2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth.

Authors:  Jennifer Johnston; Yudith Ramos-Valdes; Lee-Anne Stanton; Sadia Ladhani; Frank Beier; Gabriel E Dimattia
Journal:  Transgenic Res       Date:  2010-02-20       Impact factor: 2.788

3.  Modulation of extracellular matrix protein phosphorylation alters mineralization in differentiating chick limb-bud mesenchymal cell micromass cultures.

Authors:  Adele L Boskey; Stephen B Doty; Valery Kudryashov; Philipp Mayer-Kuckuk; Rani Roy; Itzhak Binderman
Journal:  Bone       Date:  2008-02-13       Impact factor: 4.398

4.  Hip geometry variation is associated with bone mineralization pathway gene variants: The Framingham Study.

Authors:  Ching-Lung Cheung; Gregory Livshits; Yanhua Zhou; James B Meigs; Jarred B McAteer; Jose C Florez; L Adrienne Cupples; Serkalem Demissie; Douglas P Kiel; David Karasik
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

5.  Hypophosphatasia - pathophysiology and treatment.

Authors:  José Luis Millán; Horacio Plotkin
Journal:  Actual osteol       Date:  2012-09-01

Review 6.  Regulation and function of the FGF23/klotho endocrine pathways.

Authors:  Aline Martin; Valentin David; L Darryl Quarles
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

7.  FGF2 stimulation of the pyrophosphate-generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2.

Authors:  Nan E Hatch; Yan Li; Renny T Franceschi
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

8.  Osteoblast differentiation stage-specific expression of the pyrophosphate-generating enzyme PC-1.

Authors:  Nan E Hatch; Renny T Franceschi
Journal:  Cells Tissues Organs       Date:  2008-08-13       Impact factor: 2.481

9.  Osteogenic differentiation of mesenchymal stem cells on the bimodal polymer polyurethane/polyacrylonitrile containing cellulose phosphate nanowhisker.

Authors:  Arash Padash; Raheleh Halabian; Ali Salimi; Negar Motakef Kazemi; Mohsen Shahrousvand
Journal:  Hum Cell       Date:  2020-10-22       Impact factor: 4.174

10.  Proteoliposomes harboring alkaline phosphatase and nucleotide pyrophosphatase as matrix vesicle biomimetics.

Authors:  Ana Maria S Simão; Manisha C Yadav; Sonoko Narisawa; Mayte Bolean; Joao Martins Pizauro; Marc F Hoylaerts; Pietro Ciancaglini; José Luis Millán
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.